Takeda Türkiye emphasizes the importance of early diagnosis in Multiple Myeloma, a treatable cancer in which early diagnosis and appropriate treatment can improve patients’ quality of life. Takeda Türkiye has created the website, www.yolculugumm.com, to raise awareness about early diagnosis.
Ömür Mangaloğlu, General Manager of Takeda Türkiye, shared his views: “At Takeda, we attach great importance to research in the field of oncology. Our goal is to improve the quality of life for cancer patients and expand treatment options. In line with this, we conduct R&D studies covering a wide range from hematologic cancers to solid tumors. Additionally, we collaborate with researchers to discover and develop treatment options through clinical trials.”
“On the Yolculugumm website, we have created two separate sections, one for those who want to learn about the disease and another for healthcare professionals. The section is designed for healthcare professionals, especially Turkish hematologists, and serves as a digital library where they can access content on the latest developments in multiple myeloma treatment,” he added.
